Clinical trial
Control of Asthma Patients Symptomatic on Inhaled Corticosteroids
NCT00330070 · Inflazyme Pharmaceuticals Ltd, Industry · Completed
Key facts
| NCT number | NCT00330070 |
|---|---|
| Title | Control of Asthma Patients Symptomatic on Inhaled Corticosteroids |
| Official title | An 8 Week, Randomized, Double-Blind, Parallel Group, Multicenter Trial Comparing the Efficacy and Safety of Oral IPL512,602 to Placebo in Subjects With Moderate to Severe Persistent Asthma Inadequately Controlled on Inhaled Corticosteroids |
| Lead sponsor | Inflazyme Pharmaceuticals Ltd, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | IPL512, 602 20 mg once daily, 602 Matching Placebo once daily |
| Enrollment | 200 |
| Start date | May 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | May 25, 2006 |
| Last update posted | Feb 16, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: